KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Gross Profit (2016 - 2025)

Historic Gross Profit for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $6.9 billion.

  • Amgen's Gross Profit rose 1533.31% to $6.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $24.7 billion, marking a year-over-year increase of 2016.92%. This contributed to the annual value of $24.7 billion for FY2025, which is 2016.92% up from last year.
  • Amgen's Gross Profit amounted to $6.9 billion in Q4 2025, which was up 1533.31% from $6.5 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Gross Profit registered a high of $6.9 billion during Q4 2025, and its lowest value of $4.2 billion during Q1 2024.
  • Moreover, its 5-year median value for Gross Profit was $5.1 billion (2021), whereas its average is $5.2 billion.
  • As far as peak fluctuations go, Amgen's Gross Profit plummeted by 624.33% in 2023, and later skyrocketed by 2468.71% in 2025.
  • Amgen's Gross Profit (Quarter) stood at $5.1 billion in 2021, then dropped by 0.7% to $5.1 billion in 2022, then dropped by 0.16% to $5.1 billion in 2023, then rose by 17.51% to $6.0 billion in 2024, then rose by 15.33% to $6.9 billion in 2025.
  • Its Gross Profit stands at $6.9 billion for Q4 2025, versus $6.5 billion for Q3 2025 and $6.2 billion for Q2 2025.